Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users
- 23 October 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 27 (16), 2559-2566
- https://doi.org/10.1097/qad.0b013e328363bff2
Abstract
Objective: To examine temporal trends and predictors of linkage to HIV care, longitudinal retention in care and viral suppression among injection drug users (IDUs) infected with HIV. Design: Community-based, prospective cohort study. Methods: We prospectively studied 790 HIV-infected IDUs participating in the AIDS Linked to the Intravenous Experience (ALIVE) study from 1998 through 2011. IDUs were considered linked to care if they attended any HIV care visit during follow-up and retained in care if they reported HIV clinic attendance at every semi-annual study visit. We used logistic regression to identify predictors of poor retention in care and failure to achieve sustained viral suppression in response to ART. Results: Of 790 HIV-infected IDUs studied, 740 (93.6%) were ever linked to care. The majority of IDUs (76.7%) received ART at some point during observation and of these, most (85.4%) achieved viral suppression. However, over a median of 8.7 years of follow-up, only 241 (30.5%) IDUs were continuously retained with no 6-month lapses in HIV care and only 63 (10.2%) had sustained viral suppression at every study visit after first receiving ART. Suboptimal engagement in care was associated with poor access to medical care, active drug use, and incarceration. Conclusion: Compared with national estimates of retention in care and virologic suppression in the United States, IDUs are substantially less likely to remain fully engaged in HIV care. Strategies to optimize HIV care should acknowledge the elevated risk of poor engagement in care among IDUs.This publication has 35 references indexed in Scilit:
- Sustained Viral Suppression in HIV-Infected Patients Receiving Antiretroviral TherapyJAMA, 2012
- Social and Environmental Predictors of Plasma HIV RNA Rebound Among Injection Drug Users Treated With Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Incarceration Predicts Virologic Failure for HIV-Infected Injection Drug Users Receiving Antiretroviral TherapyClinical Infectious Diseases, 2011
- Dramatic Decline in the HIV-1 RNA Level Over Calendar Time in a Large Urban HIV PracticeClinical Infectious Diseases, 2011
- Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based studyThe Lancet, 2010
- Nonstructured Treatment Interruptions Among Injection Drug Users in Baltimore, MDJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Missed Visits and Mortality among Patients Establishing Initial Outpatient HIV TreatmentClinical Infectious Diseases, 2009
- Racial Disparities in HIV Virologic Failure: Do Missed Visits Matter?JAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?Journal of General Internal Medicine, 2006
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986